125 related articles for article (PubMed ID: 33079062)
1. Do not forget megakaryocytes morphology when you deal with chronic myeloid leukaemia.
Rieu JB; Tavitian S; Vergez F; Largeaud L
Ann Biol Clin (Paris); 2020 Dec; 78(6):691-692. PubMed ID: 33079062
[No Abstract] [Full Text] [Related]
2. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera.
FRANZEN S; STRENGER G; ZAJICEK J
Acta Haematol; 1961; 26():182-93. PubMed ID: 13894731
[No Abstract] [Full Text] [Related]
3. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
Lichtman MA
Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
[No Abstract] [Full Text] [Related]
4. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
[TBL] [Abstract][Full Text] [Related]
5. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
So CC; Wan TS; Yip SF; Ma SK; Lam CC; Chan LC
Br J Haematol; 2007 May; 137(4):377. PubMed ID: 17374140
[No Abstract] [Full Text] [Related]
6. CD34-positive dwarf megakaryocytes in chronic myeloid leukemia are not indicators of disease progression.
Bhuyan B; Padhi S
Indian J Pathol Microbiol; 2023; 66(2):421-422. PubMed ID: 37077103
[No Abstract] [Full Text] [Related]
7. Another set of guidelines for chronic myeloid leukaemia.
Clark RE
Br J Haematol; 2020 Oct; 191(2):147-149. PubMed ID: 32712951
[No Abstract] [Full Text] [Related]
8. Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation.
Pajor L; Kereskai L; Zsdrál K; Nagy Z; Vass JA; Jáksó P; Radványi G
Histopathology; 2003 Jan; 42(1):53-60. PubMed ID: 12493025
[TBL] [Abstract][Full Text] [Related]
9. Concomitant diagnosis of chronic myeloid leukaemia and myeloma.
Looi W; Zargari A; Dun K; Grigoriadis G; Fedele P; Gregory GP; Low MSY
Pathology; 2022 Jun; 54(4):493-495. PubMed ID: 34776244
[No Abstract] [Full Text] [Related]
10. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukaemia. I. Some observations on chronic myeloid leukaemia.
GALTON DA
Br J Radiol; 1953 Jun; 26(306):285-90. PubMed ID: 13051542
[No Abstract] [Full Text] [Related]
12. Histamine and histaminase in chronic myeloid leukaemia of man: histamine in the blood of chronic myeloid leukaemia.
THIERSCH JB
Aust J Exp Biol Med Sci; 1947 Mar; 25():73-7. PubMed ID: 20266429
[No Abstract] [Full Text] [Related]
13. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in-situ hybridization (FISH) reveals that in chronic myelogenous leukaemia (CML) following interferon-alpha therapy, normalization of megakaryocyte size is associated with the loss of bcr/abl translocation.
Thiele J; Schmitz B; Gross H; Kvasnicka HM; Niederle N; Leder LD; Fischer R
Histopathology; 1997 Sep; 31(3):215-21. PubMed ID: 9354890
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization study.
Thiele J; Kvasnicka HM; Varus E; Ollig E; Schmitt-Graeff A; Staib P; Griesshammer M
Leuk Lymphoma; 2004 Aug; 45(8):1627-31. PubMed ID: 15370216
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukaemia in megakaryocytic crisis.
Ranjitkumar S; Lindeman R
Br J Haematol; 2002 Jun; 117(3):487. PubMed ID: 12028013
[No Abstract] [Full Text] [Related]
17. Chemotherapy of leukaemia. I. Myleran in the treatment of chronic myeloid leukaemia.
GREIG HB
S Afr Med J; 1956 Apr; 30(15):357-60. PubMed ID: 13324391
[No Abstract] [Full Text] [Related]
18. Managing children with chronic myeloid leukaemia.
Baccarani M
Br J Haematol; 2015 Jun; 169(5):759-60. PubMed ID: 25430625
[No Abstract] [Full Text] [Related]
19. Evaluation of two CE-IVD tests for
Folta A; Jurcek T; Kubesova B; Zackova D; Semerad L; Mayer J; Jeziskova I
Leuk Lymphoma; 2021 May; 62(5):1239-1242. PubMed ID: 33356699
[No Abstract] [Full Text] [Related]
20. Chronic myeloid leukaemia.
PINEY A
Br J Clin Pract; 1956 Oct; 10(10):643; passim. PubMed ID: 13374173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
